Study sought to determine if response to upfront treatment in children and adolescents with Hodgkin lymphoma is influenced by race/ethnicity.
The addition of bevacizumab to temozolomide-based chemotherapy was also associated with higher rates of grade 3 or higher thrombocytopenia and anemia.
As more and more patients undergo immunotherapy treatments, understanding possible side effects on cognitive function is an important research gap.
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure.
Survivors of childhood cancers who were treated with anthracyclines are at increased risk for developing breast cancer.
Working group reviewed bone complications to form recommendations for management of bone health.
Burden of childhood cancers disproportionately affects populations in resource-limited settings.
The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.
A primary outcome measure for phase 1 of the trial is determining the safety of oral LOXO-292.
After phase 1, the study will expand in a second phase to test the efficacy of these drugs at the determine dosage.
